A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
| Status: | Archived |
|---|---|
| Conditions: | Alzheimer Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2010 |
| End Date: | June 2012 |
Plasma Amyloid Beta Species After a Single Solanezumab Infusion in Nondemented Individuals and Those With Mild Dementia of the Alzheimer's Type
The purpose of this trial is to compare the average change in the amount of amyloid beta
species in blood after an infusion of solanezumab.
We found this trial at
1
site
Click here to add this to my saved trials
